{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:49:57Z","timestamp":1778694597274,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Program of Hunan Provincial Health Commission","award":["20200341"],"award-info":[{"award-number":["20200341"]}]},{"name":"Key laboratory fund of Hunan Province","award":["2018tP1028"],"award-info":[{"award-number":["2018tP1028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to identify the candidate biomarkers and pathways associated with psoriasis. GSE13355 and GSE14905 were extracted from the Gene Expression Omnibus (GEO) database. Then the differentially expressed genes (DEGs) with |logFC|\u2009&gt;\u20092 and adjusted <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 were chosen. In addition, the Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses for DEGs were performed. Then, the GO terms with <jats:italic>P\u2009&lt;<\/jats:italic>\u00a00.05 and overlap coefficient greater than 0.5 were integrated by EnrichmentMap. Additionally, risk subpathways analysis for DEGs was also conducted by using the iSubpathwayMiner package to obtain more psoriasis-related DEGs and pathways. Finally, protein-protein interaction (PPI) network analysis was performed to identify the hub genes, and the DGIdb database was utilized to search for the candidate drugs for psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 127 DEGs which were mostly associated with keratinization, keratinocyte differentiation, and epidermal cell differentiation biological processes were identified. Based on these GO terms, 3 modules (human skin, epidermis and cuticle differentiation, and enzyme activity) were constructed. Moreover, 9 risk subpathways such as steroid hormone biosynthesis, folate biosynthesis, and pyrimidine metabolism were screened. Finally, PPI network analysis demonstrated that <jats:italic>CXCL10<\/jats:italic> was the hub gene with the highest degree, and <jats:italic>CXCR2<\/jats:italic>, <jats:italic>CXCL10<\/jats:italic>, <jats:italic>IVL<\/jats:italic>, <jats:italic>OASL<\/jats:italic>, and <jats:italic>ISG15<\/jats:italic> were the potential gene targets of the drugs for treating psoriasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Psoriasis may be mostly caused by keratinization, keratinocyte differentiation, and epidermal cell differentiation; the pathogeneses were more related with pathways such as steroid hormone biosynthesis, folate biosynthesis, and pyrimidine metabolism. Besides, some psoriasis-related genes such as <jats:italic>SPRR<\/jats:italic> genes, <jats:italic>HSD11B1<\/jats:italic>, <jats:italic>GGH<\/jats:italic>, <jats:italic>CXCR2<\/jats:italic>, <jats:italic>IVL<\/jats:italic>, <jats:italic>OASL<\/jats:italic>, <jats:italic>ISG15<\/jats:italic>, and <jats:italic>CXCL10<\/jats:italic> may be important targets in psoriatic therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41065-020-00141-1","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:03:46Z","timestamp":1594829026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis"],"prefix":"10.1186","volume":"157","author":[{"given":"Yongqi","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"issue":"5","key":"141_CR1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/jdv.15443","volume":"33","author":"P Mease","year":"2019","unstructured":"Mease P, Palmer J, Hur P, Strober B, Lebwohl M, Karki C, et al. Utilization of the validated psoriasis epidemiology screening tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona psoriasis registry. J Eur Acad Dermatol Venereol. 2019;33(5):886\u201392.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"141_CR2","first-page":"305","volume":"154","author":"CS De","year":"2019","unstructured":"De CS, Caldarola G, Moretta G, Piscitelli L, Ricceri F, Prignano F. Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2019;154(3):305\u201314.","journal-title":"Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia"},{"issue":"3","key":"141_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"141_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"I Michalek","year":"2017","unstructured":"Michalek I, Loring B, John S. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"141_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","volume":"10","author":"M Kunz","year":"2019","unstructured":"Kunz M, Simon JC, Saalbach A. Psoriasis: obesity and fatty acids. Front Immunol. 2019;10:1807.","journal-title":"Front Immunol"},{"issue":"6","key":"141_CR6","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1111\/jdv.16244","volume":"34","author":"H Yang","year":"2020","unstructured":"Yang H, Tan Q, Chen G, Chen J, Fu Z, Ren F, et al. Plasma retinol as a predictive biomarker of disease activity and response to acitretin monotherapy in children with generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2020;34(6):e270\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7130","key":"141_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866\u201373.","journal-title":"Nature."},{"issue":"2","key":"141_CR8","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jisp.2018.09.008","volume":"19","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Xu JH. Investigation of psoriasis susceptibility loci in psoriatic arthritis and a generalized Pustular psoriasis cohort. J Investigative Dermatol Symposium Proc. 2018;19(2):S83\u2013s5.","journal-title":"J Investigative Dermatol Symposium Proc"},{"key":"141_CR9","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1038\/ncomms5331","volume":"5","author":"Y Sheng","year":"2014","unstructured":"Sheng Y, Jin X, Xu J, Gao J, Du X, Duan D, et al. Sequencing-based approach identified three new susceptibility loci for psoriasis. Nat Commun. 2014;5:4331.","journal-title":"Nat Commun"},{"issue":"2","key":"141_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways. Nat Genet. 2009;41(2):199.","journal-title":"Nat Genet"},{"issue":"4","key":"141_CR11","doi-asserted-by":"publisher","first-page":"e18266","DOI":"10.1371\/journal.pone.0018266","volume":"6","author":"WR Swindell","year":"2011","unstructured":"Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, et al. Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One. 2011;6(4):e18266.","journal-title":"PLoS One"},{"issue":"5","key":"141_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.22270\/jddt.v9i5.3535","volume":"9","author":"K El-Reshaid","year":"2019","unstructured":"El-Reshaid K, Shaima A-B. Long-term maintenance therapy with cyclosporine a in adults with generalized pustular psoriasis. J Drug Delivery Therapeutics. 2019;9(5):19\u201321.","journal-title":"J Drug Delivery Therapeutics"},{"issue":"8","key":"141_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/cells8080807","volume":"8","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yin M, Zhang L-j. Keratin 6, 16 and 17\u2014Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis. Cells. 2019;8(8):807.","journal-title":"Cells"},{"issue":"3","key":"141_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1006\/geno.1993.1240","volume":"16","author":"S Gibbs","year":"1993","unstructured":"Gibbs S, Fijneman R, Wiegant J, van Kessel AG, van de Putte P, Backendorf C. Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics. 1993;16(3):630\u20137.","journal-title":"Genomics."},{"issue":"2","key":"141_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1600-0625.2008.00769.x","volume":"18","author":"K Kainu","year":"2008","unstructured":"Kainu K, Kivinen K, Zucchelli M, Suomela S, Kere J, Inerot A, et al. Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish. Swedish Irish Families&nbsp Experimental Dermatology. 2008;18(2):109\u201315.","journal-title":"Swedish Irish Families&nbsp Experimental Dermatology"},{"issue":"3","key":"141_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<366::AID-JCP7>3.0.CO;2-8","volume":"182","author":"S Kondo","year":"2000","unstructured":"Kondo S, Yoneta A, Yazawa H, Kamada A, Jimbow K. Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. J Cell Physiol. 2000;182(3):366\u201370.","journal-title":"J Cell Physiol"},{"issue":"6","key":"141_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.tube.2013.07.008","volume":"93","author":"L D\u2019Attilio","year":"2013","unstructured":"D\u2019Attilio L, Diaz A, Santucci N, Bongiovanni B, Gardenez W, Marchesini M, et al. Levels of inflammatory cytokines, adrenal steroids, and mRNA for GRalpha, GRbeta and 11betaHSD1 in TB pleurisy. Tuberculosis (Edinb). 2013;93(6):635\u201341.","journal-title":"Tuberculosis (Edinb)"},{"key":"141_CR18","doi-asserted-by":"crossref","unstructured":"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, et al. 11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci. 2014;111(24):E2482\u201391.","DOI":"10.1073\/pnas.1323681111"},{"key":"141_CR19","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3389\/fimmu.2019.02220","volume":"10","author":"LM Sevilla","year":"2019","unstructured":"Sevilla LM, P\u00e9rez P. Glucocorticoids and glucocorticoid-induced-Leucine-zipper (GILZ) in psoriasis. Front Immunol. 2019;10:2220.","journal-title":"Front Immunol"},{"issue":"2","key":"141_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2133.2008.08898.x","volume":"160","author":"RB Warren","year":"2009","unstructured":"Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JN, et al. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. Br J Dermatol. 2009;160(2):438\u201341.","journal-title":"Br J Dermatol"},{"issue":"5","key":"141_CR21","first-page":"4011","volume":"18","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Yu Q, Gong Y, Liu Z, Xu H, Wang Y, et al. Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis. Exp Therapeutic Med. 2019;18(5):4011\u201321.","journal-title":"Exp Therapeutic Med"},{"issue":"1","key":"141_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1006\/bbrc.1995.1626","volume":"210","author":"R Strieter","year":"1995","unstructured":"Strieter R, Kunkel S, Arenberg D, Burdick M, Polverini P. Interferon [gamma]-inducible protein-10 (IP-10), a member of the CXC chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun. 1995;210(1):51\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"141_CR23","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol. 2002;168(7):3195\u2013204.","journal-title":"J Immunol"},{"key":"141_CR24","doi-asserted-by":"publisher","unstructured":"Abji F, Lee K, Math M, Pollock R, Machhar R, Cook R, et al. Declining levels of serum CXCL10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker? Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.18940.\u00a0[Published online ahead of print, 2020 Feb 9].","DOI":"10.1111\/bjd.18940"},{"issue":"7","key":"141_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380720","volume":"338","author":"FH Epstein","year":"1998","unstructured":"Epstein FH, Luster AD. Chemokines\u2014chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338(7):436\u201345.","journal-title":"N Engl J Med"},{"issue":"3","key":"141_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/jid.2008.273","volume":"129","author":"H Chen","year":"2009","unstructured":"Chen H, Toh TK, Szeverenyi I, Ong RT, Theng CT, McLean WH, et al. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J Investigative Dermatol. 2009;129(3):606\u201314.","journal-title":"J Investigative Dermatol"},{"key":"141_CR27","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1038\/emm.2014.110","volume":"47","author":"UY Choi","year":"2015","unstructured":"Choi UY, Kang JS, Hwang YS, Kim YJ. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med. 2015;47:e144.","journal-title":"Exp Mol Med"},{"issue":"10","key":"141_CR28","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/jdv.13091","volume":"29","author":"RA Raposo","year":"2015","unstructured":"Raposo RA, Gupta R, Abdel-Mohsen M, Dimon M, Debbaneh M, Jiang W, et al. Antiviral gene expression in psoriasis. J Eur Acad Dermatol Venereol. 2015;29(10):1951\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"141_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics."},{"issue":"3","key":"141_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics."},{"issue":"9","key":"141_CR31","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21(9):2067\u201375.","journal-title":"Bioinformatics."},{"issue":"3","key":"141_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3892\/etm.2017.4805","volume":"14","author":"W Zhao","year":"2017","unstructured":"Zhao W, Wang D, Zhao J, Zhao W. Bioinformatic analysis of retinal gene function and expression in diabetic rats. Exp Therapeutic Med. 2017;14(3):2485\u201392.","journal-title":"Exp Therapeutic Med"},{"issue":"5","key":"141_CR33","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3.","journal-title":"Genome Biol"},{"issue":"11","key":"141_CR34","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"141_CR35","volume-title":"Package \u2018iSubpathwayMiner\u2019","author":"C Li","year":"2013","unstructured":"Li C, Li MC. Package \u2018iSubpathwayMiner\u2019; 2013."},{"issue":"D1","key":"141_CR36","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(D1):D808\u2013D15.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"141_CR37","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00520-018-4096-2","volume":"26","author":"J Kirk","year":"2018","unstructured":"Kirk J, Shah N, Noll B, Stevens CB, Lawler M, Mougeot FB, et al. Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2018;26(8):2695\u2013705.","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-020-00141-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-020-00141-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-020-00141-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T23:16:02Z","timestamp":1626304562000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-020-00141-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1186\/s41065-020-00141-1","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}